Liang Zhao

Dr. Liang Zhao

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
MZMengmeng Zhou
Mengmeng Zhou
HWHao Wang
Hao Wang
JCJindong Chen
Jindong Chen
LZLiang Zhao
Liang Zhao

29 January 2018 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
HWHao Wang
Hao Wang
JCJindong Chen
Jindong Chen
LZLiang Zhao
Liang Zhao

15 April 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
HDHuangdong Dai
Huangdong Dai
NZNaishi Zhao
Naishi Zhao
HLHua Liu
Hua Liu
YZYue Zheng
Yue Zheng
LZLiang Zhao
Liang Zhao
Atrial fibrosis is a key contributor to atrial fibrillation (AF). Long non-coding ribonucleic acids (lncRNAs) were demonstrated to exhibit a key role in fibrotic remodeling; however, the function of nuclear-enriched abundant transcript 1 (NEAT1) in atrial fibrosis remains unclear. In the present study, we showed that NEAT1 was upregulated in atrial tissues of AF patients and was positively related to collagen I (coll I) and collagen III (coll III) expressions. Furthermore, the deletion of NEAT1 attenuated angiotensin II (Ang II)-caused atrial fibroblast proliferation, migration, and collagen production. We further observed that NEAT1 knockdown improved Ang II caused mouse atrial fibrosis in in vivo experiments. Moreover, we demonstrated that NEAT1 could negatively regulate miR-320 expression by acting as a competitive endogenous RNA (ceRNA). miR-320 directly targeted neuronal per arnt sim domain protein 2 (NPAS2) and suppressed its expression. We observed that NEAT1 exerted its function via the miR-320–NPAS2 axis in cardiac fibroblasts. These findings indicate that NEAT1 exerts a significant effect on atrial fibrosis and that this lncRNA is a new potential molecular target for AF treatment.

1 February 2021 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
HWHao Wang
Hao Wang
ZWZhexin Wang
Zhexin Wang
MZMengmeng Zhou
Mengmeng Zhou
JCJindong Chen
Jindong Chen
FYFeng Yao
Feng Yao
Ben HeBen He
Ben He
Background: This study assessed the incidence and risk factors (RFs) of postoperative atrial fibrillation (POAF) and its impact on clinical outcomes in patients undergoing pneumonectomy for lung cancer. Methods: Between 2013 and 2018, this monocentric retrospective study enrolled 324 consecutive pneumonectomy patients for primary lung cancer from our institution and 350 lobectomy and 349 segmentectomy cases matched by age, sex and body mass index (BMI). RF for POAF and postoperative death in pneumonectomy patients were assessed by logistic regression, and long-term outcomes after a median follow-up of 30 (range, 2–61) months by Cox proportional hazard model. Electrophysiology study (EPS) files of 30 AF patients with lung resection history were reviewed. Results: POAF developed more often after pneumonectomy than lobectomy and segmentectomy (23.2% vs. 6.6% vs. 1.4%, respectively; P60 years and left atrial diameter (LAd) ≥35 mm as independent predictors. POAF, infection and hemorrhage were independent RFs for perioperative death after pneumonectomy; however, POAF was not RF for long-term death. Pulmonary vein (PV) trigger was identified in 60% (18/30) of AF patients with lung resection history, with stump PVs being more active than non-stump PVs (38.2% vs. 10.5%, P<0.001). Conclusions: Post-pneumonectomy AF, with remarkable incidence, risk and independent predictors including age >60 years and LAd ≥35 mm, was mostly solitary and possibly secondary to stump and non-stump PV triggers. POAF, along with infection and hemorrhage, was a RF for perioperative death.

2 September 2021 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
JCJindong Chen
Jindong Chen
MZMengmeng Zhou
Mengmeng Zhou
HWHao Wang
Hao Wang
ZZZhihuang Zheng
Zhihuang Zheng
WRWenwen Rong
Wenwen Rong
LZLiang Zhao
Liang Zhao

8 August 2018 in Journal of International Medical Research
Verified
Journal Article
Open access
CLChanghong Lu
Changhong Lu
JLJunfang Li
Junfang Li
WWWugang Wang
Wugang Wang
KGKun Gong
Kun Gong
LZLiang Zhao
Liang Zhao
XFXiuxiu Fu
Xiuxiu Fu
Objective: A patent foramen ovale (PFO) is detected frequently by echocardiography. However, a thrombus trapped in a PFO is relatively rare. We herein describe a rare case of a 51-year-old patient with pulmonary embolism in which a large thrombus-in-transit through a PFO was found by echocardiography and disappeared after treatment. Methods: A 51-year-old woman presented with a 1-week history of chest tightness, unspecified chest pain, and shortness of breath. Echocardiography revealed a large thrombus trapped in a PFO with increased pulmonary artery pressure, which is a very rare and critical condition. Results: The patient was treated with thrombolysis and anticoagulation and discharged from the hospital with an uneventful recovery. Conclusion: Our treatment of the present patient achieved a satisfactory result, but it may not be applicable to every patient. Echocardiography is a readily available and safe tool for demonstrating the size, location, and extent of a thrombus, and it plays an important role in the early diagnosis and treatment evaluation for patients with a thrombus trapped in a PFO with concurrent pulmonary embolism.